While synapse loss correlates closely with symptoms in Alzheimer’s disease [51] and therefore neurodegeneration is an important target of MRI imaging, it is also well established that amyloid and tau-pathology can impair brain function through synaptotoxicity. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.